Color changing drug molecules as built in stability indicators

 Corresponding author: Prathmesh Yogesh Punde Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution License 4.0. Color changing drug molecules as built in stability indicators Prathmesh Yogesh Punde * School of Pharmaceutical Sciences, Sandip University. Mahiravni, Nashik422213, Maharashtra, India. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(03), 131–135 Publication history: Received on 28 July 2025; revised on 04 September 2025; accepted on 06 September 2025 Article DOI: https://doi.org/10.30574/wjbphs.2025.23.3.0812 Abstract Antibiotic degradation compromises safety and efficacy but integrating chromogenic moieties into the drug structure allows built-in visual indicators. By coupling antibiotics with chromophores or pH-sensitive dyes that respond to triggers like hydrolysis, pH shifts, oxidation, or heat, the drug can remain one color when stable and change visibly upon degradation. This report explores the underlying mechanisms and design strategies for developing such colorimetric antibiotic indicators. We review common antibiotic degradation pathways and their triggers, discuss classes of chromogenic groups (e.g. pH indicators, spirolactams, leuco dyes), and outline synthetic approaches (e.g. cleavable linkers, prodrug conjugates, polymer encapsulation). Illustrative examples include natural cases (e.g. tetracycline darkens upon epimerization [1] cefotaxime turning yellow with hydrolytic impurity [2] and engineered indicators (e.g. a bromophenol/phenolphthalein time‐temperature indicator for amoxicillin syrup [3]. We highlight historical context and recent research (2018–2024) and discuss practical challenges. Keywords: Antibiotic Stability; Chromogenic Indicator; Colorimetric Sensor; Drug Expiration; Shelf-Life Monitoring; Built-In Indicator 1. Introduction Antibiotics often have limited shelf‐lives due to chemical instability. Hydrolysis, oxidation, photodegradation, and other processes can degrade active antibiotic molecules into inactive or even toxic products [4]. Conventional expiration dating relies on stability testing (ICH conditions) and assumes proper storage, yet in practice patients may unknowingly consume degraded drugs if packaging or storage conditions fail [1]. Visual cues such as color change are an intuitive way to signal loss of potency: for example, tetracycline famously darkens from yellow to brown/gray as it epimerizes and forms toxic 4-epianhydrotetracycline, and injectable cefotaxime solutions gradually intensify in yellow hue with accumulating impurities. These observations suggest that intrinsic color changes often accompany drug degradation. Recent advances in smart pharmaceuticals have led to the development of self-indicating antibiotics that visibly change color upon degradation, removing the need for external sensors or labels. This is achieved by chemically embedding chromogenic moieties into the drug structure, which respond to degradation triggers like pH shifts, temperature, moisture, and oxidation. These indicators stay inactive under normal conditions but shift their conformation or electronic state to produce a visible color change when degradation occurs. This report outlines the molecular design principles behind such systems, including acid-base dyes, redox-sensitive chromophores, and spirocyclic switches, as well as coupling techniques like prodrug linkers and polymeric attachments. It also reviews antibiotic degradation pathways, presents recent experimental examples, and discusses regulatory and practical considerations for future development. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(03), 131–135 132 2. Discussion 2.1. Physicochemical Triggers for Antibiotic Degradation Antibiotic instability arises from several chemical triggers. Hydrolysis is a major pathway for β-lactams (penicillins, cephalosporins), ester or amide prodrugs, and some macrolides. For example, cefotaxime (a cephalosporin) degrades by moisture and heat, forming impurities that impart a yellow color. Studies show cefotaxime sodium solutions initially pale yellow become intensely yellow upon prolonged exposure to moisture, heat, or extreme pH [4]. In one 12-hour stability study, cefotaxime in saline grew notably more yellow over time, an effect correlated with rising impurity peaks [2]. This underscores that the apparent color grade tracks impurity profiles. pH changes accompany many degradation reactions. Acidic or basic byproducts can shift solution pH, which in turn can turn on pH-sensitive chromophores. For instance, hydrolytic breakdown of an antibiotic might generate a carboxylic acid; local acidification could be sensed by an indicator. Many natural antibiotics also contain ionizable groups (e.g. tetracyclines with phenolic/OH moieties) whose protonation state affects conjugation and color. Tetracycline HCl itself is yellow and darkens (to brown/gray) in moist air or light; the underlying 4-epianhydrotetracycline chromophore appears grayish. Thus, tetracycline offers a built-in example of a drug whose conjugated ring structure changes color when altered by environment [2]. Degradation triggers such as oxidation, pH shifts, hydrolysis, and heat can each be paired with specific indicator chemistries to enable self-reporting antibiotics. Oxidation may cleave conjugated systems or form colored products like quinones, while heat and light accelerate these effects, either directly or by promoting hydrolysis. Though most antibiotics lack intrinsic chromophores, oxidation-sensitive dyes or thermochromic elements can be attached to detect changes. pH indicators like phenolphthalein or bromocresol change color within specific pH ranges, hydrolysis can release latent chromophores from prodrugs, and leuco dyes may become colored upon oxidation. Combining multiple sensing elements, such as pHand redox-responsive components, could enhance detection accuracy and reliability. 2.2. Molecular Design of Chromogenic Antibiotics To create a self-indicating antibiotic, one must merge a chromogenic moiety with the drug molecule such that the indicator’s color state depends on the drug’s integrity. Two broad strategies emerge: 2.2.1. Covalent Conjugation (Prodrug Approach) This strategy links a color-changing scaffold to the antibiotic so that degradation triggers a visible shift. For example, attaching a rhodamine spirolactam via an ester keeps it colorless until hydrolysis opens the ring, revealing color. Likewise, capping phenolphthalein with a degradable group mask its color until drug breakdown restores it. These systems mimic fluorogenic prodrugs but are designed for visible, not fluorescent, signaling. 2.2.2. Physical Entrapment or Matrix Sensors Embed a colorimetric sensor in the drug formulation (e.g. in a polymeric coating, pill excipient, or microcapsule) that interacts only with the drug matrix. For example, an agar or polymer film containing bromophenol blue and phenolphthalein can be placed adjacent to an aqueous antibiotic solution. As acid (e.g. acetic acid) diffuses out of degrading amoxicillin syrup, the indicator layer changes from violet to yellow [3]. This is technically a separate device (a time-temperature indicator (TTI)) rather than a chemical bond to the drug, but it achieves a similar goal of real-time monitoring of drug quality. Kuswandi and co-workers developed such an agar-TTI for amoxicillin syrup: as the syrup ages, acetic acid released by antibiotic breakdown diffuses into the indicator layer, causing a violet-to-brown-to-yellow transition. The final yellow state corresponded to the drug concentration falling below acceptable levels. Although this is an external sensor, it illustrates how chemical byproducts of degradation (acid) can trigger a visible change. Below we focus on molecular strategies integrated into the API structure. Key considerations include 2.2.3. Choice of Chromophore Ndicators must remain stable during storage but activate upon degradation. pH-sensitive dyes (e.g., azo dyes, anthocyanins, phenolphthalein) change color via protonation shifts. Spirocyclic dyes like rhodamines convert to colored forms when triggered by pH or metal ions. Leuco dyes are colorless until oxidized into visible chromophores. Metal– ligand complexes or Au/Ag nanoparticles can also produce plasmonic color changes through aggregation or ligand loss, as seen in nanoparticle-based sensing systems. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(03), 131–135 133 2.2.4. Trigger Coupling Indicators must be linked to the same degradation pathway that deactivates the drug. For hydrolysis-prone drugs, chromophores can be attached via hydrolyzable linkers (e.g., esters), releasing or activating the dye upon bond cleavage. For instance, a halochromic dye esterified to a β-lactam could stay colorless until hydrolysis frees a colored phenolate. pH shifts from degradation, like HCl release in penicillin breakdown, can be detected by integrated pH indicators. Oxidative degradation can be paired with redox-sensitive dyes that activate upon exposure to peroxides. 2.2.5. Molecular Triggers and Structural Changes Effective designs rely on predictable electronic shifts. Anthocyanins change from red (cation) to blue/green (neutral) to yellow (chalcone) as pH increases, enabling visible hue shifts when conjugated to a drug. Spirolactams like rhodamine B hydrazide stay colorless until ring-opening by acid or metal yields a fluorescent form ideal for indicating drug cleavage. Azo dyes also shift color through redox changes of the azo bond, offering another strategy for degradationresponsive indicators. Synthetic StrategiesImplementing these ideas requires feasible synthetic routes. Options include 2.2.6. Direct Covalent Attachment Indicators can be chemically bound to drug functional groups, like forming amides or carbamates with chromogenic acids. The drug must retain activity, so attachment shouldn’t block key sites. Some designs create neutral prodrugs that become active and colored upon cleavage similar to protease-activatable systems using fluorescence, but here applied to visible color change. 2.2.7. Prodrug and Spacer Linkers Introduce an enzymatically or chemically cleavable spacer between drug and dye. For example, a phenolic antibiotic could be acetylated with a dye-bearing acyl. Upon hydrolysis (or esterase action), the colored phenolate is liberated. Synthetic schemes might follow standard prodrug esterification methods, but safety of the dye byproduct must be assessed. 2.2.8. Polymer/Matrix Integration Copolymerize or co-crystallize the drug with a colorimetric agent. While not a single molecule, one could embed a responsive dye into a polymeric tablet coating that gradually interacts with the drug as it diffuses or degrades. Nanoencapsulation of drug and dye together in microcapsules could similarly allow a shared environment. 2.2.9. Surface Chemistry on Particles For long-acting formulations like injectable microspheres, surface dyes can be used to signal matrix degradation via color change. Though a physical rather than molecular method, it provides visual feedback. Crucially, the indicator must remain stable and non-leaching during storage, staying colorless or neutral until degradation begins. Since pills often already have color, indicators should activate only upon inspection or in solution, keeping the visual cue subtle and purposeful. 2.3. Recent Research 2.3.1. Tetracyclines The classic case of self-indication is tetracycline. Tetracycline HCl is a yellow crystalline powder that darkens in moist air or under light. This color change is intrinsic: poor storage leads to formation of 4-epianhydrotetracycline, which is grayish and toxic. Egbuna (2019) reported unexplained tetracycline capsules turning yellow to dark gray within months, noting that “the color change is a sign of degradation” to toxic products. While this is a deleterious byproduct rather than a designed indicator, it confirms that the extended conjugated anthraquinone-like structure of tetracyclines can shift visible color upon structural rearrangement. A deliberate design could harness similar chemistry: for example, blocking the tetrazine or phenolic oxygens with removable protecting groups so that deprotection yields a new conjugated system. 2.3.2. Cephalosporins Cephalosporins, like cefotaxime, contain a dihydrothiazine ring with conjugation. Sun et al. studied color stability of cefotaxime sodium and noted that differences in solution color correlated with impurity levels. Degradation by World Journal of Biology Pharmacy and Health Sciences, 2025, 23(03), 131–135 134 moisture/heat/acid produces unsaturated degradation products (dihydrodiol or dihydrothiazine-opening products) that absorb at visible wavelengths. A potential indicator design would attach a phenolic dye to the C3 leaving group: hydrolysis of that group during β-lactam ring opening could release a colored phenolate. Alternatively, the drug could co-crystallize with a chromogenic stabilizer that reacts to released ammonia or acids. 2.3.3. Bromophenol/Phenolphthalein TTI A time–temperature indicator (TTI) film with bromophenol blue and phenolphthalein changed from violet to brown/yellow as amoxicillin syrup degraded and released acetic acid. Though external, this system demonstrates how pH shifts from drug breakdown can trigger visible color changes using simple acid–base indicators. 2.3.4. Prodrug/NP Systems In a recent example, antimicrobial peptides on gold or silver nanoparticles changed color (yellow to blue) upon enzymatic cleavage by fungal proteases, causing nanoparticle aggregation. A similar concept could apply to antibiotics, where degradation-triggered cleavage leads to plasmonic color change, using nanoparticle-based rather than smallmolecule systems. 2.3.5. General Colorimetric Sensors Beyond antibiotics, colorimetric dyes have been widely used for shelf-life indicators in food. Anthocyanin-polymer films change from pink to purple upon spoilage gas evolution [6]. These works often emphasize visual simplicity: large color shifts detectable by eye. In pharmaceutical context, similar films or labels could be co-packaged with drugs for an indirect signal. However, embedding the indicator at the molecular level within the antibiotic is the most elegant solution, albeit chemically challenging. 2.4. Structural Mechanisms Leading to Color Change The key to any indicator is a change in electronic conjugation. For example: 2.4.1. Acid–Base Indicators Weak acids or bases like phenolphthalein and anthocyanins change color with pH due to altered conjugation phenolphthalein shifts from colorless (acidic) to pink (basic), while anthocyanins go from red (low pH) to blue/green (high pH). Embedding such moieties in antibiotics could visually signal degradation via pH changes, such as base formation. 2.4.2. Spirocyclic Dyes Rhodamine B hydrazide is nonfluorescent/colorless until it coordinates metal or acid, opening the spiro ring to yield a conjugated xanthene chromophore. In an antibiotic indicator, one could hide such a spirolactam in a protective cage until cleavage yields the colored form. 2.4.3. Oxidation Indicators Leuco dyes (e.g. leucomalachite green) are colorless reduced forms; oxidation (e.g. by oxygen or peroxide) converts them to brightly colored oxides. If an antibiotic’s degradation generates reactive oxygen species, a nearby leuco dye could be triggered. 2.4.4. Group Transfer Indicators Some designs involve covalent transfer. For example, a nitroaromatic might undergo reduction to an amine (colorless → colored). This is more bioassay style but could translate if storing drug produces nitrite/nitrate. Future Directions Research on self-indicating drugs is nascent. Future work could explore novel stimuli-responsive linkers that cleave under very specific conditions (e.g. exposure to light above 300 nm, creating UV-triggered color changes). Integration with digital readouts (smartphone apps reading subtle color shifts) could amplify usefulness. Development of universal indicator scaffolds that can be appended to diverse antibiotics is also attractive. For example, developing a “universal” azo-dye linker that attaches to any amine or hydroxyl group and produces a consistent color change. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(03), 131–135 135 Continued interdisciplinary work bridging medicinal chemistry, materials science, and regulatory science will be crucial. While most published examples are proof-of-concept, the increasing emphasis on medication safety and the value of real-time quality monitoring suggest that such technologies could see practical deployment. 3. Conclusion Embedding colorimetric stability indicators into antibiotic molecules offers a compelling approach to visually detect expiration or degradation. Mechanistically, this leverages known indicator chemistries (pH dyes, redox dyes, spirocycles) aligned with drug-specific triggers (hydrolysis, acid generation, oxidation). We have reviewed the principles and design strategies for such chromogenic antibiotics, citing examples like natural tetracycline darkening and engineered TTI films for amoxicillin. While promising, these systems must balance chemical feasibility, drug activity, and safety. Regulatory approval will hinge on demonstrating that the indicator does not compromise efficacy or create harmful byproducts. Future work may expand the toolbox of indicator reactions, yielding smart antibiotics that self-report potency. Such advances could significantly improve medication safety, especially in resource-limited settings where cold-chain and expiry tracking are problematic. References [1] Egbuna C. An unusual color change in tetracycline HCl powder – from drug to poison. Med J Dr DY Patil Vidyapeeth. 2019;12(2):152-154. [2] D’Huart E, Vigneron J, Blaise F, Charmillon A, Demoré B. Physicochemical stability of cefotaxime sodium in polypropylene syringes at high concentrations for intensive care units. Pharm Technol Hosp Pharm. 2019;4(2):59-67. [3] Kuswandi B, Kurniawan A. Development of acetic acid based time-temperature indicator for monitoring of amoxicillin quality. Chem Sensors. 2014;4:1-7. [4] Sun H, Cui X, Liu B, Zhang J. Relationship between the color stability and impurity profile of cefotaxime sodium. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1063:235-244. [5] Amer L, Retout M, Jokerst JV. Activatable prodrug for controlled release of an antimicrobial peptide via the proteases overexpressed in Candida albicans and Porphyromonas gingivalis. Theranostics. 2024;14(4):17811793. [6] Kossyvaki D, Contardi M, Athanassiou A, Fragouli D. Colorimetric indicators based on anthocyanin polymer composites: A review. Polymers. 2022;14(19):4129. [7] Sakiroff L, Kim JH, Whitford TJ, Twardowski R, Holmgren A, Casanova-Nakayama A, et al. Evaluation of color changes during stability studies using photodiode array spectrophotometry to supplement visual examination. Sci Rep. 2022;12:14110. [8] Palmer AC, Angelino E, Kishony R. Chemical decay of an antibiotic inverts selection for resistance. Nat Chem Biol. 2010;6(2):105-107.